Dr. G's Weightloss
455 Southwest 78th Avenue · Plantation, FL 33324
4.6(37 Google reviews · 7 in past year)
Accepts insuranceSemaglutide todayTirzepatide today
Listing updated Oct 2, 2026
Elevate Med and Aesthetics
Elevate Med and Aesthetics · 9781 West Broward Boulevard · Plantation, FL 33324
5.0· 120 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Elevate Med and Aesthetics is a medical practice in Plantation, Florida, whose listed services include weight-loss care, hormone therapy and IV therapy. On Google it holds a 5.0-star rating across 120 reviews dating back to 2022, with 37 in the past year. Reviewers most often mention the staff and the providers' knowledge, and 16 reviews mention results. With no medications named, it is worth asking directly about its weight-management options.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 5.0
Google rating · 120 reviews
37
reviews in the past year (avg ★ 5.0)
1
reviews mention GLP-1 medications
8
reviews mention weight loss
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-21. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 120 Google reviews. Of the 100 reviews we analyzed, 100 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff51 reviews
- Knowledgeable, professional providers34 reviews
- Weight-loss results16 reviews
- Clean, comfortable office11 reviews
Common complaints
No negative reviews among those we analyzed.
5★
99
4★
1
3★
0
2★
0
1★
0
Most recent Google reviews
Carol★★★★★2026-09-21Great prompt service. Amy and the staff are nice and welcoming!
Donna Z.★★★★★2026-08-28They are always ready for me when I get there! Everyone is extremely knowledgeable and friendly. Can't wait to add my services to experience.
Monica P.★★★★★2026-08-18Great people very good informatio
Alyssa H.★★★★★2026-07-28Amazing service! Did lip filler & got exactly what I asked for
jacalyn f.★★★★★2026-07-24The ladies at the front desk were super nice and helpful! Very clean restroom too!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Plantation
Accepts insurance
Listing updated Oct 2, 2026
Amalfy Med Spa
8320 West Sunrise Boulevard · Plantation, FL 33322
5.0(16 Google reviews · 1 in past year)
Accepts insuranceSemaglutide todayTirzepatide today
Listing updated Oct 2, 2026
Reliv Again Wellness
8211 West Broward Boulevard · Plantation, FL 33324
4.9(85 Google reviews · 1 in past year)
Accepts insurance
Listing updated Oct 2, 2026
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs